4/A: CareDx Director Corrects Stock Option Exercise Price in Amended SEC Filing
SEC Filing
Arthur Torres, a director at CareDx, Inc., filed an amendment to a Form 4 to correct the exercise price of a stock option.
Summary
- Arthur Torres, a director of CareDx, Inc., filed an amended Form 4 with the SEC.
- The amendment corrects the exercise price of a stock option previously reported.
- The original filing was made on June 18, 2024, and this amendment is dated June 20, 2024.
- The stock option grants Torres the right to buy 16,048 shares of CareDx common stock.
- The corrected exercise price is $14.19 per share.
- The options vest monthly, starting July 14, 2024, and continuing through June 14, 2025.
- The options expire on June 14, 2034.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing correcting a minor error, so it has a neutral sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date of earliest transaction (stock option grant) |
| 06/14/2034 | Expiration date of the stock option |
| 06/18/2024 | Date of original Form 4 filing |
| 06/20/2024 | Date of amended Form 4/A filing |
| 07/14/2024 | First vesting date of the stock option |
| 06/14/2025 | Last vesting date of the stock option |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.